Variant report

Variant	nsv481673
Chromosome Location	chr6:162355913-162480718
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:12)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:162397480..162399223-chr6:162401761..162404565,2	K562	blood:
2	chr6:162350457..162353351-chr6:162353923..162356207,2	K562	blood:
3	chr6:162470841..162473078-chr6:162475586..162477804,2	MCF-7	breast:
4	chr6:162397480..162399223-chr6:162401761..162404565,2	K562	blood:
5	chr6:162380873..162382939-chr6:162388150..162390123,2	K562	blood:
6	chr6:162470841..162473078-chr6:162475586..162477804,2	MCF-7	breast:
7	chr6:162436271..162438282-chr6:162512437..162514970,2	K562	blood:
8	chr6:162380873..162382939-chr6:162388150..162390123,2	K562	blood:
9	chr6:162372183..162373880-chr6:162375416..162378006,2	K562	blood:
10	chr6:162400767..162402435-chr6:162406575..162409112,2	K562	blood:
11	chr6:162372183..162373880-chr6:162375416..162378006,2	K562	blood:
12	chr6:162400767..162402435-chr6:162406575..162409112,2	K562	blood:

No data

Extended variants
information (count: 3966 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:3966 , 50 per page) page: 1 2 3 4 5 6 7 ... 80

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs184592301	chr6:162355941-162355942	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs7759885	chr6:162355976-162355977	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs145336325	chr6:162355992-162355993	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs144481358	chr6:162356016-162356017	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs370116623	chr6:162356042-162356043	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs377264266	chr6:162356131-162356132	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs369324262	chr6:162356132-162356133	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs373323548	chr6:162356133-162356134	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs35474695	chr6:162356134-162356135	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs199505133	chr6:162356135-162356136	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs6909226	chr6:162356172-162356173	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs370735914	chr6:162356203-162356204	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs140089018	chr6:162356204-162356205	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs116050692	chr6:162356206-162356207	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs535981540	chr6:162356220-162356221	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs78548992	chr6:162356280-162356281	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs112946538	chr6:162356309-162356310	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs377708654	chr6:162356315-162356316	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs572647870	chr6:162356325-162356326	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs541317435	chr6:162356363-162356364	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs145514082	chr6:162356400-162356401	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs147717697	chr6:162356414-162356415	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs543463413	chr6:162356415-162356416	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs186698807	chr6:162356455-162356456	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs191107008	chr6:162356510-162356511	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs377469655	chr6:162356586-162356587	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs34896573	chr6:162356603-162356604	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs564681964	chr6:162356604-162356605	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs376445639	chr6:162356627-162356628	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs141066318	chr6:162356683-162356684	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs79685736	chr6:162356699-162356700	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs551343371	chr6:162356704-162356705	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs185077801	chr6:162356706-162356707	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs571232604	chr6:162356751-162356752	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs189544529	chr6:162356784-162356785	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs193191250	chr6:162356806-162356807	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs528188874	chr6:162356851-162356852	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs142444331	chr6:162356897-162356898	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs114895316	chr6:162356905-162356906	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs555835403	chr6:162356906-162356907	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs185086665	chr6:162356914-162356915	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs535237000	chr6:162356987-162356988	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs558461591	chr6:162357041-162357042	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs112502716	chr6:162357065-162357066	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs372486513	chr6:162357080-162357081	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs375645818	chr6:162357095-162357096	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs113079762	chr6:162357128-162357129	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs12213142	chr6:162357176-162357177	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs544161669	chr6:162357194-162357195	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs151256599	chr6:162357197-162357198	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	20967226	CNVD
Bipolar disorder	19114987	CNVD
Schizophrenia	23813976	CNVD
early-passage human iPS cells	21368824	CNVD
Parkinson disease	21829596	CNVD

Chromatin state (count:312 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162336200-162357200	Weak transcription	Aorta	Aorta
2	chr6:162354200-162372200	Weak transcription	Right Atrium	heart
3	chr6:162357200-162357400	ZNF genes & repeats	Aorta	Aorta
4	chr6:162357400-162362200	Weak transcription	Aorta	Aorta
5	chr6:162361800-162362400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr6:162361800-162362400	Enhancers	Pancreas	Pancrea
7	chr6:162362200-162362800	Enhancers	Fetal Intestine Large	intestine
8	chr6:162364600-162364800	Enhancers	H9 Cell Line	embryonic stem cell
9	chr6:162364600-162364800	Enhancers	HUES48 Cell Line	embryonic stem cell
10	chr6:162364800-162365400	Weak transcription	HUES48 Cell Line	embryonic stem cell
11	chr6:162364800-162365600	Enhancers	H1 Cell Line	embryonic stem cell
12	chr6:162364800-162366200	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr6:162364800-162377000	Weak transcription	H9 Cell Line	embryonic stem cell
14	chr6:162365400-162365600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
15	chr6:162365400-162365600	Enhancers	iPS-15b Cell Line	embryonic stem cell
16	chr6:162365400-162365800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr6:162365400-162366600	Enhancers	HUES48 Cell Line	embryonic stem cell
18	chr6:162365400-162366800	Enhancers	iPS-20b Cell Line	embryonic stem cell
19	chr6:162365400-162368600	Enhancers	iPS-18 Cell Line	embryonic stem cell
20	chr6:162365600-162366600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr6:162365600-162367600	Weak transcription	H1 Cell Line	embryonic stem cell
22	chr6:162365600-162367800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
23	chr6:162365800-162366000	Enhancers	Cortex derived primary cultured neurospheres	brain
24	chr6:162365800-162366200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
25	chr6:162365800-162367000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr6:162365800-162367200	Enhancers	HUES64 Cell Line	embryonic stem cell
27	chr6:162366000-162370000	Weak transcription	Cortex derived primary cultured neurospheres	brain
28	chr6:162366200-162366400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
29	chr6:162366200-162368400	Weak transcription	HUES6 Cell Line	embryonic stem cell
30	chr6:162366400-162368800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
31	chr6:162366600-162366800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr6:162366600-162367600	Weak transcription	HUES48 Cell Line	embryonic stem cell
33	chr6:162366800-162367600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr6:162366800-162367800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
35	chr6:162367000-162367400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr6:162367200-162368200	Weak transcription	HUES64 Cell Line	embryonic stem cell
37	chr6:162367400-162367800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr6:162367400-162368000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr6:162367400-162368000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr6:162367400-162368000	Enhancers	Fetal Brain Male	brain
41	chr6:162367600-162367800	Enhancers	H1 Cell Line	embryonic stem cell
42	chr6:162367600-162367800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
43	chr6:162367600-162368600	Enhancers	HUES48 Cell Line	embryonic stem cell
44	chr6:162367800-162368400	Weak transcription	H1 Cell Line	embryonic stem cell
45	chr6:162367800-162368600	Enhancers	iPS-20b Cell Line	embryonic stem cell
46	chr6:162367800-162368800	Enhancers	iPS-15b Cell Line	embryonic stem cell
47	chr6:162368000-162377200	Weak transcription	Fetal Brain Male	brain
48	chr6:162368200-162368600	Enhancers	HUES64 Cell Line	embryonic stem cell
49	chr6:162368400-162368600	Enhancers	H1 Cell Line	embryonic stem cell
50	chr6:162368400-162368600	Enhancers	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links